The Latest Breaking News from AstraZeneca

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 27, 2022

Vaccinologist Sarah Gilbert: ‘We need to be better prepared for a new pandemic’

The woman who co-developed the AstraZeneca vaccine on reassuring doubters, her new book and having a baby penguin named after her

The Guardian - UK · Jun 26, 2022

What Are Whales Doing With AstraZeneca

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jun 24, 2022

EU regulator authorizes COVID shot made by France's Valneva

The European Medicines Agency says it is recommending the authorization of the coronavirus vaccine made by French pharmaceutical Valneva, making it the sixth shot to be given the green light in Europe

The Independent UK · Jun 23, 2022

Dad 'paralysed by Covid vaccine' in rare disorder leaves hospital after 420 days

Anthony Shingler, 58, was diagnosed with a very rare condition that affects the nerves and leaves around one in five people with long-term problems such as being unable to walk without assistance

Daily Mirror · Jun 23, 2022

Woman gets £120,000 NHS payout after singer fiancé died following Covid jab

Vikki Split is believed to be the first Brit to receive vaccine damage payment compensation

Manchester Evening News · Jun 22, 2022

Woman gets £120,000 payout from NHS after singer fiancé dies from Covid-19 jab

Vikki Spit, from Alston, Cumbria, filed for the claim under the NHS Business Services Authority's Vaccine Damage Payment Scheme after her fiancé Lord Zion died in May 2021

Daily Mirror · Jun 22, 2022

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jun 21, 2022

Peer review: Can this critical step in the publication of science research be kinder?

Democracy has been called the least worst system of government. Peer review is the least worst system for assessing the merit of scientific work.

The Conversation · Jun 20, 2022

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

Benzinga · Jun 17, 2022